Abstract #300791

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2002 Program page
JSM 2002 Abstract #300791
Activity Number: 23
Type: Contributed
Date/Time: Sunday, August 11, 2002 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section*
Abstract - #300791
Title: Crossover Trials in Diabetes Research
Author(s): Chien-Feng Chen*+ and Jie Huang
Affiliation(s): Eli Lilly and Company and Eli Lilly and Company
Address: 1641 Killarney Way, Indianapolis, Indiana, 46285, USA
Keywords: crossover ; diabetes
Abstract:

Crossover designs are efficient alternatives to parallel designs. Sample size reduction is approximately four-to-one in diabetes research, with hemoglobin A1c as the primary variable. Challenge occurs on understanding and handling potential carry-over effect. This presentation starts with fundamentals: design, model and analyses with SAS programs. One of the main focuses is to understand the nature of the carry-over effect. The well accepted two-stage approach by Grizzle (1965) possesses serious flaws. Summarization of critiques on Grizzle's approach and different views of handling the carry-over effect from Freeman (1989), Lehmacher (1991, and Senn (1993, 1997) are discussed. Lastly, we assess the influence of carry-over effect from results of several clinical trials to evaluate the legitimacy on the use of crossover designs in diabetes research. Recommendation to the conduct and analysis of crossover trials are also provided.

  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2002 program

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002